eGain prices an AI pivot before fiscal 2027 funds it

Summary: U.S. short Watchlist, reject for current execution. eGain (NASDAQ: EGAN) was quoted at $5.67 at 2026-09-04 15:31:00 UTC, down 20.32% from the prior close after the company reported fiscal 2026 results on September 3. The fresh result is not a failed business: fiscal 2026 revenue rose 3% to $91.1 million, AI customer revenue rose 20%, AI customer ARR rose 13%, and operating cash flow was $21.2 million. The more important forward bridge is harsher. Fiscal 2027 revenue is guided to $84.5 million to $86.0 million, GAAP net income turns into a $2.0 million to $3.0 million loss, and adjusted EBITDA falls from $13.6 million or a 15% margin to only $650,000 to $1.4 million or a 1% to 2% margin. eGain defines AI customer revenue as all revenue from customers that use one or more AI offerings, including their SaaS and professional-services revenue. That is a customer-cohort metric, not standalone AI product revenue. A reference-only map of $3.85 top / $4.50 base / $7.20 bottom at 30% / 50% / 20% gives a weighted target of $4.85 and a 14.55% gross expected short return, but the credible adverse rise is 26.98% and the gross ratio is 0.76:1. Current borrow is stale, current exit quality is incomplete, and the stock has already fallen more than 20%. Keep entry.price null and execution.can_execute false. This is research, not personalized financial advice.

Run timestamp: 2026-09-04T23:31:44+08:00 (Asia/Singapore). Quote timestamps, filing periods, release times, and provider refresh times are separate.

Opportunity Ranking

Rank	Candidate	Direction	Mispricing	Evidence Freshness	Catalyst Window	Positioning	10/5 Status	Tradeability	Main Rejection Risk
1	eGain (EGAN)	Short	Fiscal 2027 revenue is guided below fiscal 2026 and adjusted EBITDA falls from a 15% margin to 1% to 2%, while the AI customer metric includes all offerings sold to customers who use AI and the share price still sits above provider net cash	Sep. 3 company release and financial tables, Sep. 4 regular-session tape and public positioning	First post-result acceptance, Q1 FY27 ending Sep. 30, and next filed quarterly bridge	1.50M shares short, 9.97% of float, 12.61 DTC; public borrow last showed 350K shares at 0.41% on Aug. 20, not current	Watchlist; reject for current execution	Average volume about 110K; earlier same-day snapshot showed a $0.07 spread, but current depth, venue quality, volume quality, exit liquidity, and live borrow are incomplete	$70.56M provider net cash, founder and institutional ownership, a Gartner category label, AI-customer growth, and short covering
2	Guidewire (GWRE)	Short	A 21.54% regular-session decline follows a strong FY26 result, but a high multiple and guidance below elevated expectations can still create a reset	Sep. 3 official result, Sep. 4 live quote and market-structure snapshots	First session and FY27 ARR, revenue, and cash conversion	6.13% of float short and 3.71 DTC; a reviewed tape showed a $18.08 displayed spread, so data quality is itself a blocker	Reject	Current quote was regular session, but the displayed spread was unusable and execution evidence was not reconciled	FY26 revenue rose 23%, ARR 19%, operating cash flow margin was 26%, and FY27 cash guidance remains strong
3	Oxford Industries (OXM)	Short	Q2 GAAP EPS included a $2.07 tariff-refund benefit, adjusted operating income was nearly flat, and guidance fell, but the stock already declined about 16.76% and the dividend and debt create a rebound path	Sep. 3 SEC exhibit and Sep. 4 regular-session quote and provider statistics	First post-result session and Q3 margin and inventory conversion	22.51% of float short and 10.03 DTC; the public borrow page was stale	Reject	Small-cap tape with current depth, locate, and exit evidence incomplete	Low valuation, debt reduction, a 7.64% provider dividend yield, and a real Tommy Bahama recovery
4	Ultragenyx (RARE)	Short	The Phase 3 Aspire study missed both primary and key secondary endpoints, but the stock rebounded 3.03% and retains a September 19 PDUFA catalyst	Sep. 2 SEC 8-K and Aug. 4 results, Sep. 4 live quote and borrow	UX111 PDUFA on Sep. 19 and commercial portfolio execution	17.00% of float short and 7.8 DTC; current public borrow showed 2.4M shares at 0.40%	Reject	Liquid enough for research, but binary approval and squeeze risk dominate	A real commercial base, two gene-therapy catalysts, and a rebound after the clinical failure

The screen used mechanism-specific searches combining "AI customer revenue includes all offerings legacy software decline fiscal year guide adjusted EBITDA cliff", "post-earnings cohort metric not standalone AI monetization small cap short", "Guidewire high-multiple guidance miss price acceptance spread", "tariff refund adjusted operating income inventory debt retail short", and "Phase 3 failure PDUFA rebound short interest borrow squeeze". Generic earnings-only queries were not used. The current-week archive was scanned by filename, headline, ticker, issuer, mechanism, direction, and signal ID. EGAN, GWRE, OXM, and RARE had no dedicated current-week article or signal when screened. NTSK, GROW, AMBA, LULU, and DOCU were excluded because they already have current-week Desk coverage.

Selected opportunity: eGain common stock, Nasdaq.

Why this one now: EGAN presents the clearest fresh forward reset. Its fiscal 2026 AI-customer headline is positive, but the company's own definition includes SaaS and professional-services revenue from every customer using an AI offering. Total revenue grew only 3%, fourth-quarter AI customer revenue grew 11%, fiscal 2027 total revenue is guided down, and the adjusted EBITDA guide implies that the pivot consumes nearly all current operating profitability. OXM has a cleaner one-time-refund issue, but the market has already recognized much of it and its dividend and debt reduction can support a rebound. GWRE and RARE have stronger catalysts on the other side. EGAN is the best research opportunity, not a qualified trade.

What should surprise the reader: “AI customer revenue” is not the same as AI product revenue. eGain defines it as total revenue generated from customers that actively use one or more AI offerings, including all offerings associated with those customers. A customer can be counted in the AI cohort while its legacy SaaS or professional-services revenue supplies much of the reported amount. The next surprise is the fiscal 2027 guide: a company described as all-in on AI guides total revenue down 6.5% at the midpoint and adjusted EBITDA down about 92.5% at the midpoint. The pivot may be strategically rational, but the current filing does not show that it funds itself.

Why This Is the Best Opportunity Right Now

The strongest bear case is not that eGain has no product-market fit. The company was named a Leader in Gartner's inaugural Magic Quadrant for Customer Service Knowledge Management Systems, fiscal 2026 AI customer revenue grew 20%, AI customer ARR grew 13%, and cash plus cash equivalents ended at $73.3 million. Fiscal 2026 operating cash flow was $21.2 million, and the company repurchased approximately 1.607 million shares for $11.5 million. Those are verified facts, not a caricature of the counterparty. eGain fiscal 2026 results

The disagreement is about the quality and direction of the next dollar. Fiscal 2026 total revenue was $91.1 million, up 3%, but fourth-quarter revenue was $22.2 million, down from $23.2 million. Fourth-quarter AI customer revenue grew 11%, below the full-year 20% rate. SaaS revenue for the full year was $85.3 million, up 4%, while professional-services revenue fell 10% to $5.9 million. The company describes the legacy business as in managed decline, which makes the AI-customer label less informative than standalone AI attach, expansion, retention, and collected revenue would be. eGain fiscal 2026 financial tables

The forward bridge is more severe than the headline growth. Fiscal 2027 revenue guidance is $84.5 million to $86.0 million, versus fiscal 2026 revenue of $91.136 million. The midpoint implies a 6.5% decline. Fiscal 2027 adjusted EBITDA is guided to $650,000 to $1.4 million, versus $13.623 million in fiscal 2026. The midpoint falls by about 92.5%, and the guided margin falls from 15% to roughly 1% to 2%. GAAP net income also turns into a loss of $2.0 million to $3.0 million. These are management forecasts, not an independent estimate, but they are the most direct evidence that the AI pivot is not yet financing itself. eGain fiscal 2026 results

The cash cushion limits immediate distress. Provider fields show $73.34 million of cash, $2.78 million of debt, and $70.56 million of net cash, or $2.57 per share, against a provider market cap of $155.50 million. The balance sheet also carries $48.765 million of current deferred revenue, $32.775 million of accounts receivable, and $26.172 million of outstanding common shares at June 30, 2026, with 7.761 million treasury shares. Net cash is resilience, not a price floor. It gives management time to invest, and it makes a short vulnerable to a strategic buyer, a buyback, or a renewed AI narrative. eGain fiscal 2026 financial tables and eGain StockAnalysis statistics

The central test is therefore narrow: can the company preserve a cash-generating legacy base while converting an AI customer cohort into incremental paid revenue and margin? The current release does not answer that. It shows a category label, a customer-cohort metric, and a forward profitability reset. The short case is an evidence-timing claim, not a claim that eGain's product is worthless.

Why This Can Move More Than 5% Soon

The result already moved the stock more than 20%, so the correct question is whether the first gap is accepted or partially retraced. The latest StockAnalysis regular-session snapshot showed $5.67 at 11:31:00 a.m. EDT, with an open of $5.50, a prior close of $7.11, and a day range of $5.41 to $5.74. A finance-feed observation at 11:18:21 a.m. EDT showed $5.58, a $5.26 to $5.70 intraday range, and 532,684 shares. The two current observations are close but not identical, so the price state is not a single execution mark. eGain StockAnalysis quote and eGain finance-feed quote

First regular-session acceptance: The current price is already in the post-result range. A close below $5.41 with normal spread, depth, venue quality, and exit liquidity would show that the guide reset is being priced beyond the first gap. A durable close above $7.11 would show that cash, AI positioning, and short covering are winning.
Q1 fiscal 2027 guide conversion: The quarter ends September 30, 2026. Management guides total revenue to $20.9 million to $21.4 million, AI customer revenue to $13.7 million to $14.0 million, and adjusted EBITDA to $1.4 million to $1.9 million or a 7% to 9% margin. The test is total revenue, standalone AI attach, SaaS and services mix, operating cash, and actual EBITDA, not the AI-customer label alone. eGain fiscal 2026 results
Fiscal 2027 cash and margin conversion: The full-year adjusted EBITDA guide is $650,000 to $1.4 million. The cheapest confirming observation is a quarter in which AI-customer growth does not prevent lower total revenue, lower margin, or weaker cash. The cheapest disconfirming observation is a filed quarter with total revenue above guide, standalone AI revenue or attach, stable legacy retention, and operating cash that funds the investment.
Capital returns and denominator: eGain repurchased shares at an average of $7.16 in fiscal 2026, but the program and cash balance do not guarantee future repurchases. The next filing must show actual repurchases, cash after investment, issued and treasury shares, and the current denominator.

10/5 Asymmetry Gate

The holding window is September 4 through the first reported Q1 fiscal 2027 result, with the quarter ending September 30, 2026 and the release date not verified. The $5.67 regular-session mark is a reference observation, not a verified executable entry.

Test	Calculation or evidence	Result
Reference price	$5.67 at 2026-09-04 15:31:00 UTC, regular session	Reference only
Favorable base move	Short from $5.67 to $4.50: ($5.67 - $4.50) / $5.67	+20.63% before costs
Credible adverse move	Short from $5.67 to $7.20: ($7.20 - $5.67) / $5.67	-26.98% before costs
Gross favorable-to-adverse ratio	20.63% / 26.98%	0.76:1, below 2:1
Illustrative public borrow carry	0.41% annualized public feed x 57 / 365, only if unchanged	About 0.06% before spread, slippage, recall, and buy-in
Price-only weighted target	30% x $3.85 + 50% x $4.50 + 20% x $7.20	$4.85
Price-only gross expected short return	($5.67 - $4.85) / $5.67	+14.55% before costs
After-cost value	Entry, current spread, depth, venue, exit liquidity, live locate, current borrow, recall, buy-in, Q1 filing, standalone AI revenue, and next-quarter cash bridge are incomplete	Cannot compute responsibly
Measurement basis	Verified entry or reference-only	Reference-only
Classification	10/5 downside, economics, and execution gates	Watchlist research; Reject for current trade

The base case clears the favorable 10% discovery test. The credible adverse rise is 26.98%, so the five-percent adverse bound fails by a wide margin. The gross reward-to-adverse ratio is 0.76:1, so the economics fail before borrow, spread, slippage, and path effects. The weighted target is a price-only scenario map, not an actionable expected value. I do not have sufficient reliable data to quantify net after-cost EV accurately.

Canonical rubric: Trade-qualified requires a verified executable entry, a favorable base-case decline of at least 10%, a credible adverse rise no greater than 5%, at least 2:1 gross reward to adverse risk, and completed direction-specific execution gates. Watchlist means the research may be useful but the entry, economics, or evidence is incomplete. Reject means the candidate fails the hurdle or lacks a safe trade expression. EGAN is Watchlist research and Reject for current execution.

What Should Surprise the Reader

The first surprise is definitional. eGain's AI customer revenue is not revenue from AI products alone. It is the total revenue generated from customers that actively utilize one or more AI offerings, and it includes all offerings associated with those customers. A customer can enter the AI cohort while legacy SaaS or professional services still supplies the revenue. Without standalone AI attach, cohort expansion, and renewal disclosure, the metric cannot prove that the AI pivot is incremental monetization. eGain fiscal 2026 results

The second surprise is the forward margin cliff. Fiscal 2026 adjusted EBITDA was $13.623 million, or roughly 15% of revenue. Fiscal 2027 guidance is $650,000 to $1.4 million, or 1% to 2% of revenue. The company is not guiding to a gradual margin trade for a high-growth year. It is guiding to a near-total earnings reset while total revenue declines. The investment may be sensible, but the current evidence does not show that it is financed by new AI dollars.

The third surprise is that the prior-year GAAP comparison is noisy in the other direction. Fiscal 2025 Q4 net income included an approximately $29.0 million tax benefit from releasing most of the valuation allowance. The current Q4 GAAP net income of $1.3 million versus $30.9 million therefore overstates the operating deterioration if read without the tax bridge. The clean comparison is current revenue, current operating margin, current adjusted EBITDA, current cash flow, and the forward guide. eGain fiscal 2026 financial tables

The market may be right to keep the stock above net cash. A named Gartner category, a real customer base, positive fiscal 2026 operating cash, low debt, and a founder-led company can create value even during an investment year. The short thesis is that the price needs a quicker standalone AI and cash bridge than the latest release provides.

The Setup

Facts: Fiscal 2026 revenue was $91.136 million, up 3%. AI customer revenue grew 20%, AI customer ARR grew 13%, and represented 72% of total SaaS ARR. Fiscal 2026 GAAP gross margin was 73%, non-GAAP gross margin 74%, adjusted EBITDA $13.623 million, and operating cash flow $21.2 million. Q4 total revenue was $22.2 million, down from $23.2 million, and Q4 AI customer revenue grew 11%. eGain fiscal 2026 results

Inference: The post-result decline is consistent with a market that values the fiscal 2027 guide more heavily than the Gartner label or the full-year AI-customer headline. That is a market-behavior inference, not proof that the market has fully understood the metric definition.

Assumptions: The scenario map uses $5.67, a September 4 through the first Q1 FY27 result window, and judgmental targets of $3.85, $4.50, and $7.20. The probabilities are model inputs, not market-implied odds.

Unknowns: Standalone AI product revenue, AI attach and expansion, cohort retention, customer concentration, current order and renewal state, Q1 execution, current borrow utilization, live locate, recall and buy-in terms, current top of book, depth, venue quality, volume quality, exit liquidity, the next 10-Q, cash after investment, and actual future repurchases are not all verified.

The Market Price

Observation	Value	Timestamp / session	Source and limitation
Latest regular-session quote	$5.67, down $1.45 or 20.32%; open $5.50; prior close $7.11; day range $5.41 to $5.74	Sep. 4, 2026 at 15:31:00 UTC, regular U.S. session	EGAN StockAnalysis quote; consolidated context, not a full venue or depth audit
Independent finance-feed quote	$5.58, down $1.53 or 21.52%; open $5.50; high $5.70; low $5.26; volume 532,684	Sep. 4, 2026 at 15:18:21 UTC, regular U.S. session	EGAN finance-feed quote; close in time but not the same quote feed
Top-of-book snapshot	$5.56 bid / $5.63 ask / $0.07 spread; 399,376 shares	Sep. 4, 2026 at 14:44:45 UTC, regular U.S. session	EGAN ChartExchange historical page; earlier snapshot, not current depth or exit evidence
Prior after-hours reaction	$5.20, down 27.17% from the Sep. 3 regular close	Sep. 3, 2026 at 20:59:30 UTC, after hours	EGAN ChartExchange historical page; context only, not an executable entry
Provider valuation	Market cap $155.50M, enterprise value $84.95M, TTM revenue $91.14M, forward P/E 13.28, EV-to-sales 1.37x	Provider refresh checked Sep. 4, 2026	EGAN StockAnalysis statistics; provider ratios are context, not a forward model
Provider denominator and ownership	Shares outstanding 27.45M, float 15.04M, insiders 35.47%, institutions 43.19%	Provider refresh checked Sep. 4, 2026	EGAN StockAnalysis statistics; ownership fields may use different reporting dates
Provider cash and claims	Cash $73.34M, debt $2.78M, provider net cash $70.56M or $2.57 per share	Provider refresh checked Sep. 4, 2026; balance-sheet date Jun. 30, 2026	EGAN StockAnalysis statistics; net cash is resilience, not a price floor
Filed operating result	FY26 revenue $91.136M, FY26 operating cash $21.2M, Q4 revenue $22.2M, Q4 AI customer revenue growth 11%	Year ended Jun. 30, 2026; released Sep. 3	eGain fiscal 2026 results
Filed forward guide	FY27 revenue $84.5M to $86.0M, GAAP net loss $2.0M to $3.0M, adjusted EBITDA $0.65M to $1.4M, or 1% to 2% margin	Fiscal year ending Jun. 30, 2027; released Sep. 3	eGain fiscal 2026 results
Public positioning	1.50M shares short, 9.97% of float, 12.61 DTC	Latest provider fields checked Sep. 4; public settlement date is not shown in the same field	EGAN StockAnalysis statistics and EGAN ChartExchange short interest; lagged positioning context
Public borrow context	350,000 shares available, 0.41% fee	Aug. 20, 2026 at 14:57:55 UTC, public Interactive Brokers snapshot	EGAN ChartExchange borrow page; stale and not an account-level locate

The market data are not interchangeable. StockAnalysis supplied the latest displayed quote and provider statistics. The finance feed supplied a separate intraday tape. ChartExchange supplied an earlier bid, ask, spread, after-hours print, and stale borrow snapshot. No source reviewed here provides current depth, current venue quality, current utilization, an account-level locate, recall terms, or a realistic exit-liquidity audit.

The Mispricing

The market appears to be pricing some value for an AI-enabled knowledge-management transition while recognizing the immediate fiscal 2027 guide reset. At a provider market cap of $155.50 million, eGain trades at about 1.7 times fiscal 2026 revenue and 1.37 times provider enterprise value to sales. The multiple is not extreme. The short case is not a simple high-multiple argument.

The fresh counter-fact is that the growth label and the forward income statement diverge. AI customer revenue growth of 20% is a cohort metric that includes all revenue from customers using AI offerings. Total revenue grew only 3% in fiscal 2026. Fiscal 2027 total revenue is guided lower, and adjusted EBITDA is guided down by roughly 92.5% at the midpoint. The market can rationally pay for future AI adoption, but the current release does not show standalone AI dollars offsetting legacy contraction and investment.

The market may be right because the definition is transparent, the company has a real installed customer base, and cohort expansion can precede product-level disclosure. The guidance may also be deliberately conservative during a sales and product investment cycle. A short based only on the word “AI” or on the Q4 GAAP comparison would be weak. The differentiated claim is narrower: fiscal 2027 is the first period in which the pivot must fund its own operating bridge, and management's guide says it currently does not.

The Positioning

Public positioning is crowded enough to create risk. StockAnalysis reports 1.50 million shares short, 9.97% of float, and 12.61 DTC. Insiders and institutions together represent provider ownership fields above the free float, so ownership percentages must be treated as reporting context rather than a precise current supply map. The high DTC figure means a failed short can be expensive to exit even if the thesis eventually works.

ChartExchange's reviewed Sep. 4 snapshot showed a $0.07 spread at 14:44:45 UTC, but it is an earlier point-in-time observation and does not establish current depth or exit quality. Its last public borrow snapshot showed 350,000 shares at a 0.41% fee on Aug. 20. That is stale relative to the result and not a broker-level locate. Borrow scarcity is not proven; borrow continuity is also not proven.

The price path itself is mixed. The stock fell from a $7.11 prior close to a current $5.67 quote, while the after-hours mark reached $5.20. That shows a large initial reset but not a clean continuation. The Desk therefore caps the positioning score at 3/5 and treats the short as a research context, not a pending order.

The Catalyst

The catalyst path is a sequence:

Result and first-session acceptance: The September 3 release is public, and the September 4 session is already down more than 20%. The next test is whether price holds below the prior close without a disorderly spread or whether cash and AI positioning produce a rebound.
Q1 FY27 guide conversion: The quarter ends September 30, 2026. Compare total revenue with the $20.9 million to $21.4 million guide, AI customer revenue with $13.7 million to $14.0 million, and adjusted EBITDA with $1.4 million to $1.9 million. Then separate standalone AI product revenue, legacy SaaS, professional services, cash, and the denominator.
AI cohort quality: The release's AI customer revenue definition includes all offerings from customers that use AI. The closing evidence is incremental AI attach, expansion, renewal, and collections, not the number of customers counted in the cohort.
Fiscal 2027 profitability reset: The full-year adjusted EBITDA guide is $650,000 to $1.4 million. A quarter that meets revenue but misses the margin guide would strengthen the short case; a quarter with positive operating leverage and standalone AI dollars would disconfirm it.
Capital return and cash bridge: Fiscal 2026 repurchases were real, but future authorization or founder intent is not completed demand. The next filing must reconcile cash after product and sales investment, actual repurchases, issued shares, treasury shares, and the current common denominator.

The cheapest disconfirming sequence is a regular close above $7.11, Q1 revenue and AI attach above guide, stable legacy retention, and operating cash that funds the transition. The cheapest confirming sequence is a failed price rebound, Q1 total revenue below guide or margin deterioration, and no standalone AI revenue or cash conversion in the next filing.

The Payoff

The top case is $3.85 if the fiscal 2027 guide becomes the anchor, the AI cohort fails to translate into incremental revenue, and the market values the company near its net-cash-plus-residual-business range. The base case is $4.50 if the stock gives back part of the post-result range while investors wait for Q1 evidence. The bottom case is $7.20 if the founder-led company, Gartner category label, cash balance, share repurchases, or high DTC short interest creates a rebound to above the prior close.

The map is a one-window stress exercise, not a cash floor. EGAN can gap through any planned risk limit on a customer win, buyback, takeout report, product launch, or thin-tape covering. Provider net cash reduces financing risk but does not cap the equity upside.

Price Target and Probability Map

Scenario	Probability	Target / Level	Return / Payoff	Horizon	Conditions	Evidence Quality
Top Case	30%	$3.85	+32.10% gross short return from $5.67	Sep. 4 through the first Q1 FY27 result	Total revenue declines, the AI cohort fails to show incremental attach or collections, and the market discounts the margin reset toward net cash plus a residual business	Low / Medium
Base Case	50%	$4.50	+20.63% gross short return from $5.67	Sep. 4 through the first Q1 FY27 result	The post-result gap is partly retraced while the guide, legacy decline, and standalone AI revenue remain unresolved	Medium
Bottom Case	20%	$7.20	-26.98% gross short return from $5.67	Sep. 4 through the first Q1 FY27 result	Cash, Gartner validation, founder ownership, repurchases, customer wins, or short covering creates a rebound above the prior close	Medium
Invalidation	n/a	Sustained regular close above $7.11 plus Q1 revenue, standalone AI attach, margin, cash, and denominator improvement	Thesis cancellation, not a guaranteed stop	Any time	The AI transition grows total revenue and recurring cash without consuming the guided margin bridge	High / Medium

Probability-weighted expected value: Price-only weighted target = (0.30 x $3.85) + (0.50 x $4.50) + (0.20 x $7.20) = $4.845, rounded to $4.85. Against the $5.67 reference, the price-only expected short return is 14.55% before borrow, spread, slippage, fees, recall, buy-in, and path effects. This is not an actionable EV because the entry is null and execution is incomplete.

Current market level and timestamp: $5.67 at 2026-09-04 15:31:00 UTC, regular session; finance-feed corroboration $5.58 at 2026-09-04 15:18:21 UTC.

Primary instrument: Unlevered EGAN common stock only if every short-side and market-structure gate passes. No option or leveraged expression is supported by the current evidence.

10/5 favorable base move: 20.63% decline from the reference-only basis.

10/5 credible adverse move: 26.98% rise from the reference-only basis.

10/5 measurement basis: Reference-only. No verified executable entry.

10/5 status: Watchlist research; Reject for current trade.

Confidence: Medium. The company release and financial tables are fresh, the current regular-session quote is available, and public short-interest data are visible. The AI-customer definition, current spread and depth, live borrow and locate, exit liquidity, Q1 conversion, standalone AI revenue, and next filed cash and denominator bridges remain incomplete.

The Kill Shot

The strongest counterparty argument is that eGain has a viable, cash-generating transition. It has 25 years of knowledge-management experience, a customer base that includes Global 2000 companies, a Gartner category position, positive fiscal 2026 operating cash, low debt, and net cash. The fiscal 2027 guide may reflect deliberate investment in a market that is still early. The company also repurchased shares at an average price of $7.16, which shows management has historically used capital to support the equity.

That argument wins if AI customer revenue becomes demonstrably incremental, total revenue stops shrinking, the legacy business remains profitable enough to fund investment, and adjusted EBITDA returns toward the fiscal 2026 margin without a higher share count. The most fragile load-bearing assumption for the short is not the cash balance. It is the interpretation that a customer-cohort metric will fail to become standalone paid AI monetization before the market is willing to re-rate the equity.

The short can lose even if the guide is directionally weak. A single customer win can move a $155 million company. The founder and institutions may support the stock. A buyback can reduce float. A private takeout can value the customer relationships rather than current earnings. A high DTC ratio can force covering. These paths make $7.20 a credible bottom case and keep the gross ratio below the Desk hurdle.

What Could Go Wrong

Metric conversion: AI customer revenue includes all offerings from AI-using customers today, but those customers may expand into higher-value AI products faster than the release discloses.
Gartner validation: A newly defined category can create distribution, customer trust, and partner access before standalone AI revenue is visible.
Cash resilience: Provider net cash of $70.56 million gives eGain time to fund sales, product development, and a temporary margin reset.
Founder and institutional ownership: Provider fields show 35.47% insider ownership and 43.19% institutional ownership. A small effective float can amplify demand.
Repurchases: Fiscal 2026 purchases of $11.5 million can support the share price, though authorization and past purchases do not guarantee future cancellation.
Customer concentration: A single large AI knowledge deployment can change quarterly revenue and sentiment before the next filing.
Prior-year tax noise: The fiscal 2025 Q4 tax benefit makes the GAAP comparison look worse than the recurring operating change; the short must not depend on that distortion.
Short squeeze: 9.97% of float is short with 12.61 DTC, so a rebound can be difficult to cover.
Borrow and liquidity: The last public borrow snapshot is from Aug. 20 and does not prove current availability, recall, buy-in, or settlement terms.
Already-realized move: The stock has already fallen more than 20% on the result, so the first leg of the reset is not available as a fresh short edge.

What Would Prove This Wrong

Remove the operating short thesis if the next evidence shows:

A regular-session close above $7.11 that holds with a functioning current spread, depth, venue, volume quality, and realistic exit liquidity.
Q1 FY27 total revenue above the $20.9 million to $21.4 million guide and AI customer revenue above $13.7 million to $14.0 million, with a separate disclosure of standalone AI attach or expansion.
Adjusted EBITDA and operating cash outperform the guide without relying on a one-time receipt, working-capital release, or higher equity issuance.
The fiscal 2027 revenue guide is raised back toward or above fiscal 2026 revenue, and the legacy business stops declining without a material margin sacrifice.
Actual repurchases, shares issued, treasury shares, stock compensation, and current denominator reconcile in the next filing.

An execution gate can cancel the trade expression without proving the operating thesis. If current quote, spread, depth, venue, volume quality, exit liquidity, locate, borrow, recall, buy-in, settlement, Q1 filing, standalone AI revenue, cash bridge, or denominator evidence is missing, keep entry.price null and execution.can_execute false.

Risk Audit

Risk	Why it matters	Control
Post-result rebound	The stock has already fallen from $7.11 to the mid-$5 range, and the prior close remains a natural covering reference	Do not short the first print or chase a gap; require price acceptance and a live top-of-book audit
AI-customer definition	Cohort revenue includes SaaS and professional services, so the metric can be misunderstood in either direction	Require standalone AI attach, expansion, renewal, collections, and total revenue reconciliation
Margin reset	Fiscal 2027 adjusted EBITDA guidance falls to 1% to 2% of revenue, but investment can later produce operating leverage	Compare Q1 total revenue, adjusted EBITDA, GAAP income, OCF, and FCF against the guide
Net cash	Provider net cash is $70.56M or $2.57 per share, which reduces near-term financing risk	Do not use net cash as a price floor; track cash after product, sales, leases, and repurchases
Short squeeze	12.61 DTC and 9.97% of float short can create a rapid rebound	Model $7.20 as the bottom case and verify live borrow, recall, buy-in, and replacement terms
Small-cap liquidity	Average volume is about 110K, and current depth and exit quality are not verified	No market order, leverage, margin, options, or entry before current liquidity evidence
Price-feed conflict	StockAnalysis showed $5.67 while the finance feed showed $5.58 minutes earlier	Keep one reference basis for arithmetic and re-audit current quote consistency before any decision
Prior tax benefit	Fiscal 2025 Q4 included about $29M of tax benefit, so a naive EPS comparison overstates the operating break	Use recurring revenue, operating margin, EBITDA, and cash-flow bridges rather than headline EPS

Best Trade Strategy

Instrument: Unlevered EGAN common stock only after every market and short-side gate passes. Do not use options, leverage, margin, market orders, or a no-locate short.
Entry: No executable entry now. The $5.67 regular-session observation is context, not authorization. entry.price remains null until a fresh quote, current top of book, spread, depth, venue quality, volume quality, realistic exit liquidity, broker-level locate, borrow and recall terms, settlement conditions, Q1 conversion, standalone AI-revenue evidence, and current denominator are verified.
Targets: Reference-only top $3.85, base $4.50, and bottom $7.20, with probabilities 30%, 50%, and 20%.
Invalidation: Remove the short thesis if price acceptance above $7.11 is durable and the Q1 and next filing show standalone AI monetization, total-revenue stabilization, margin recovery, cash conversion, and a reconciled denominator.
Horizon: September 4 through the first reported Q1 FY27 result, with re-underwriting after the next filing, every borrow or settlement change, the quarter ending September 30, and each repurchase or share-count disclosure.
Do not trade: Do not short because the stock is down 20%, because the word AI appears in the release, because provider net cash looks like a floor, or because a stale borrow page shows availability. Do not treat $3.85 as a floor or $7.20 as a ceiling.
Monitor: First regular close; bid, ask, spread, depth, venue; borrow fee, utilization, recall, buy-in, and locate; Q1 revenue and AI-customer definition; standalone AI attach; legacy SaaS and services; customer concentration; adjusted EBITDA; operating cash; FCF; cash after investment; repurchases; issued and treasury shares; and the next 10-Q.

Sources

eGain fiscal 2026 results - primary revenue, AI-customer metric definitions, FY26 results, FY27 guidance, cash flow, repurchases, and Gartner context.
eGain fiscal 2026 financial tables - primary condensed balance sheet, revenue mix, stock compensation, operating income, and non-GAAP reconciliation.
eGain investor-relations archive - company-hosted fiscal 2026 results and financial-materials index.
EGAN StockAnalysis quote - Sep. 4 regular-session quote, open, prior close, range, and provider market context.
EGAN StockAnalysis statistics - market cap, enterprise value, denominator, ownership, net cash, valuation, short-interest, and provider cash-flow context checked Sep. 4, 2026.
EGAN finance-feed quote - independent Sep. 4 intraday price, range, volume, and market-cap observation.
EGAN ChartExchange historical page - after-hours reaction and earlier bid, ask, spread, and volume snapshot.
EGAN ChartExchange borrow page - stale public borrow availability and fee context.
EGAN ChartExchange short-interest page - public short-interest and FINRA settlement-date methodology context.
Guidewire FY26 results - ranked GWRE alternative with ARR, revenue, margin, cash, and FY27 guidance.
GWRE StockAnalysis statistics and GWRE ChartExchange short-interest page - ranked alternative quote, valuation, positioning, and spread context.
Oxford Q2 fiscal 2026 SEC Exhibit 99.1 - ranked OXM alternative with tariff-refund, adjusted-margin, product, debt, and guidance data.
OXM StockAnalysis statistics and OXM finance-feed quote - ranked alternative quote, valuation, dividend, short-interest, and current-session context.
Ultragenyx Phase 3 Aspire SEC Form 8-K and Ultragenyx Q2 fiscal 2026 results - ranked RARE alternative with clinical failure, commercial revenue, and PDUFA context.
RARE finance-feed quote, RARE ChartExchange borrow page, and RARE short-interest data - ranked alternative current quote, borrow, and public positioning.

Research Quality Scorecard

Criterion	Score	Reason
Market disagreement	5/5	A customer-cohort AI metric and Gartner label sit beside a total-revenue decline guide and a near-total adjusted-EBITDA reset
Evidence base	5/5	Fresh company release, financial tables, regular-session quote, independent intraday feed, public short interest, and borrow context are available
Positioning and flows	3/5	Short interest, DTC, ownership, and an earlier spread are visible, but current utilization, flow, depth, exit quality, locate, and borrow continuity are missing
Catalyst path	4/5	First-session acceptance, Q1 guide conversion, AI attach, margin, cash, and denominator tests are observable
Payoff architecture	2/5	Reference-only base decline clears 10%, but the adverse rise is 26.98% and the gross ratio is 0.76:1
Invalidation discipline	4/5	Price, AI definition, guide, revenue, margin, cash, repurchase, and denominator tests are explicit
Differentiated insight	5/5	Separates AI-customer cohort revenue from standalone AI product revenue and treats the FY27 margin reset as the actual catalyst
Client value	4/5	The result remains useful as a metric-definition, margin, cash, and liquidity audit even though it rejects a short today

Total: 32/40. Classification: Watchlist research; Reject for current execution. The score cannot override the failed adverse bound, the 0.76:1 gross ratio, the null entry, the small-cap exit risk, and the incomplete current borrow and standalone AI-revenue bridges.

Bottom Line

eGain is the strongest fresh U.S.-short research candidate in this run because its September 3 result places the AI narrative and the fiscal 2027 cash bridge side by side. Fiscal 2026 revenue grew only 3% to $91.1 million. AI customer revenue grew 20%, but eGain defines that metric as all revenue from customers using an AI offering, not standalone AI product revenue. Fiscal 2027 revenue is guided down to $84.5 million to $86.0 million, while adjusted EBITDA falls from $13.623 million to $650,000 to $1.4 million.

The counterparty is real: Gartner recognition, a customer base, $21.2 million of fiscal 2026 operating cash, $73.3 million of cash, low debt, and founder and institutional ownership can support a rapid rebound. The price-only map gives a 14.55% gross expected short return from the $5.67 reference, but the credible adverse rise is 26.98%, the gross ratio is 0.76:1, and the current execution audit is incomplete. Keep entry.price null and execution.can_execute false. Re-underwrite after the first regular close and the next quarter's standalone AI attach, total revenue, margin, cash, repurchase, and denominator evidence.

AI Illustration Prompt

Create a realistic editorial illustration for The Mispricing Desk about eGain (NASDAQ: EGAN) after its September 3, 2026 fiscal 2026 result. Use a wide 16:9 composition inside a sober enterprise AI knowledge-management and financial-research lab, with dark glass, quiet server racks, brushed aluminum, paper ledgers, and documentary financial-journalism lighting. Put a main market monitor in the background reading REGULAR SESSION $5.67 / -20.32% / 11:31 AM EDT / SEPTEMBER 4, 2026, with a smaller independent tape panel reading FINANCE FEED $5.58 / -21.52% / 11:18 AM EDT. Add an after-hours event panel reading AFTER-HOURS $5.20 / -27.17% / SEPTEMBER 3 / CONTEXT NOT ENTRY. Add a smaller market-structure panel reading EARLIER BID $5.56 / ASK $5.63 / SPREAD $0.07 / DEPTH AND EXIT UNVERIFIED. Do not invent any logo other than a subtle readable The Mispricing Desk watermark.

In the center, show a split operating ledger. The left side, labeled FISCAL 2026 FILED, must read TOTAL REVENUE $91.136M / +3%, AI CUSTOMER REVENUE +20%, AI CUSTOMER ARR +13% / 72% OF TOTAL SAAS ARR, Q4 REVENUE $22.2M / -5%, Q4 AI CUSTOMER REVENUE +11%, OPERATING CASH $21.2M, and ADJUSTED EBITDA $13.623M / 15% MARGIN. Put a clear footnote below the AI customer figures: COHORT METRIC: ALL REVENUE FROM CUSTOMERS USING ONE OR MORE AI OFFERINGS, NOT STANDALONE AI PRODUCT REVENUE.

The right side, labeled FISCAL 2027 GUIDE, must read REVENUE $84.5M-$86.0M / MIDPOINT -6.5%, GAAP NET LOSS -$2.0M TO -$3.0M, ADJUSTED EBITDA $0.65M-$1.4M, ADJUSTED EBITDA MARGIN 1%-2%, Q1 REVENUE $20.9M-$21.4M, Q1 AI CUSTOMER REVENUE $13.7M-$14.0M, and Q1 ENDS SEPTEMBER 30, 2026. Draw a large red arrow from $13.623M / 15% to $0.65M-$1.4M / 1%-2% labeled PIVOT NOT YET SELF-FUNDED.

Below the ledger, show a cash and claims panel reading CASH $73.34M, DEBT $2.78M, PROVIDER NET CASH $70.56M / $2.57 PER SHARE, CURRENT DEFERRED REVENUE $48.765M, ACCOUNTS RECEIVABLE $32.775M, OUTSTANDING COMMON $26.172M AT JUNE 30, and TREASURY SHARES 7.761M. Add a small warning stamp: NET CASH IS RESILIENCE, NOT A PRICE FLOOR. Beside it, place a share-repurchase receipt reading FY26 REPURCHASE $11.5M / 1.607M SHARES / AVERAGE $7.16 / FUTURE BUYBACK UNVERIFIED.

On the left wall, show a restrained AI knowledge graph with customer folders, legacy SaaS documents, professional-services invoices, and AI agent screens feeding into one ledger. Label the folders LEGACY SAAS, PROFESSIONAL SERVICES, AI CUSTOMER COHORT, and STANDALONE AI ATTACH UNVERIFIED. Make the visual distinction between a customer using an AI feature and a separate paid AI product unmistakable. Include a small Gartner-style category plaque reading CATEGORY VALIDATION, NOT CASH CONVERSION without inventing a Gartner logo.

In the foreground, show a three-branch price map for the short thesis: TOP $3.85 / 30%, BASE $4.50 / 50%, and BOTTOM $7.20 / 20%. Add a clear red annotation reading WEIGHTED TARGET $4.85 / PRICE-ONLY EXPECTED SHORT RETURN +14.55% / ADVERSE +26.98% / RATIO 0.76:1. Add a gray gate panel reading ENTRY NULL / EXECUTION BLOCKED / CURRENT SPREAD, DEPTH, VENUE, EXIT, LOCATE, BORROW, RECALL, Q1 CONVERSION, AI ATTACH, CASH, AND DENOMINATOR UNVERIFIED. The lower edge should include a positioning strip reading 1.50M SHORT / 9.97% FLOAT / 12.61 DTC / PUBLIC BORROW 0.41% / 350K AVAILABLE ON AUG 20 / STALE PUBLIC DATA IS NOT A LOCATE.

Use charcoal, midnight blue, graphite, muted cobalt, warm paper, cool white, amber, and one controlled red accent. Make the distinctions between total revenue, AI customer cohort revenue, standalone AI product revenue, SaaS, professional services, adjusted EBITDA, GAAP loss, cash, net cash, repurchases, shares, short interest, and executable entry visually precise. No generic candlestick chart, no rocket, no coins, no hype, no personalized advice, and no claim that the short is executable. The mood should be analytical, tense, and unresolved, like a premium magazine illustration of an AI pivot waiting for its first clean revenue and cash bridge.